New insights for FOXO and cell-fate decision in HIV infection and HIV associated neurocognitive disorder

Advances in Experimental Medicine and Biology

Volumn 665, Issue , 2009, Pages 143-159

  Cui, Min ^b   Huang, Yunlong ^b   Zhao, Yong ^b   Zheng, Jialin ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR FKHRL1; TRANSCRIPTION FACTOR FOXO; TRANSCRIPTION FACTOR FOXO4; TRANSCRIPTION FACTOR FOXO6; UNCLASSIFIED DRUG; FORKHEAD TRANSCRIPTION FACTOR;

APOPTOSIS; ARTICLE; ASTROCYTE; ASTROCYTOSIS; BRAIN NERVE CELL; CD4+ T LYMPHOCYTE; CELL CYCLE ARREST; CELL DIFFERENTIATION; CELL FATE; CELL METABOLISM; CELLULAR STRESS RESPONSE; CENTRAL NERVOUS SYSTEM DAMAGE; CENTRAL NERVOUS SYSTEM DISEASE; DISEASE ASSOCIATION; HIV ASSOCIATED DEMENTIA; HOMEOSTASIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MACROPHAGE; MONOCYTE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; STEM CELL; VIRUS REPLICATION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METABOLISM; PHYSIOLOGY; REVIEW;

HUMAN IMMUNODEFICIENCY VIRUS 1;

AIDS DEMENTIA COMPLEX; FORKHEAD TRANSCRIPTION FACTORS; HIV INFECTIONS; HIV-1; HUMANS;

EID: 77952481709     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-1599-3_11     Document Type: Article

References (128)

1. Galili N. Davis RJ. FredericksWJ, et al. Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma. Nat Genet 1993; 5(3):230-235. (Pubitemid 23330384)
2. HilIionJ. Le Coniat M. Jonveaux P, et al. AF6q21. A novel parmer of the MLL gene in t(6 ; 11)(q21; q23). defines a forkhead transcriptional factor subfamily. Blood 1997; 90(9):3714-3719. (Pubitemid 27473443)
3. Anderson MJ. Viars CS. Czekay S, et al. Cloning and characterization of three human forkhead genes that comprise an FKHR-like gene subfamily. Genomics 1998; 47(2):187-199. (Pubitemid 28086844)
4. Borkhardt A. Repp R. Haas OA, et al. Cloning and characterization of AFX. the gene that fuses to MLL in acute leukemias with a t(X ; l1 )(q13; q23). Oncogene 1997; 14(2):195-202. (Pubitemid 27068305)
5. Jacobs FM. van der Heide LP.Wijchers PJ, et al. Fox06. A novel member of the FoxO class of transcription factors with distinct shuttling dynamics.J Bioi Chern 2003; 278(38):35959-35967. (Pubitemid 37139914)
6. Ho KK. Myatt SS. Lam EW. Many fork s in the path: Cycling with FoxO. Oncogene 2008 ; 27(16):2300-2311. (Pubitemid 351501781)
7. Huang H. Tindall OJ. Dynamic FoxO transcription factors.J Cell Sci 2007; 120(Pt 15):2479-2487. (Pubitemid 47323857)
8. Tran H. Brunet A. Griffith EC, et al. The many forks in FOXO's road. Sci STKE 2003; 2003(172 ):RE5.
9. Arden KC. FOXO animal models reveal a variety of diverse roles for FOXO transcription factors. Oncogene 2008; 27(16) :2345-2350. (Pubitemid 351501785)
10. Calnan DR. Brunet A. The FoxO code. Oncogene 2008; 27(16):2276-2288. (Pubitemid 351501779)
11. Brunet A. Bonni A. Zigmond MJ, et al. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 1999; 96(6) :857-868. (Pubitemid 29165088)
12. Lehtinen MK. Yuan Z. Boag PR, et al. A conserved MST-FOXO signaling pathway mediates oxidative-mess responses and extends life span. Cell 2006; 125(5):987-1001. (Pubitemid 43795191)
13. Skurk C. Maatz H. Kim HS, et al. The Akr-regulated forkhead transcription factor FOX03a controls endothelial cell viability through modulation of the caspase-8 inhibitor FLIP. J Bioi Chern 2004; 279(2) :1513-1525. (Pubitemid 38082681)
14. Yusuf 1. Zhu X. Kharas MG, et al. Optimal B-ce1l proliferation requires phosphoinositide 3-kinase-dependent inactivation of FOXO transcr iption factors. Blood 2004; 104(3):784-787. (Pubitemid 38970574)
15. Greer EL. Brunet A. FOXO transcription factors in ageing and cancer. Acta Physiol (Oxf) 2008; 192(1):19-28. (Pubitemid 350284502)
16. Fu Z. Tindall OJ. FOXOs. cancer and regulation of apoptosis. Oncogene 2008; 27(16):2312-2319.
17. Hu ang H. Regan KM. Wang F, et al. Skp2 inhibits FOXO1 in tumor suppression through ubiqu irin-med iated degradation. Proc Narl Acad Sci USA 2005; 102(5):1649-1654. (Pubitemid 40209222)
18. Tothova Z. Gilliland DG. FoxO transcription factors and stem cell homeostasis: Insights from the hematopoietic system. Cell Stem Cell 2007; 1(2):140-152. (Pubitemid 47215597)
19. Rena G. Guo S. Cichy SC, et al. Phosphor ylation of the transcription factor forkhead family member FKHR by protein kinase B.J Bioi Chern 1999; 274(24) :17179-17183.
20. TomizawaM. Kumar A. Perrot V, et al. Insulin inhibits the activation of transcription by a C-terminal fragment of the forkhead transcript ion factor FKHR. A mechanism for insulin inhibition of insulin-like growth factor-binding protein-I transcription.J Bioi Chern 2000; 275(10):7289-7295. (Pubitemid 30146280)
21. Guo S. Rena G. Cichy S, et al. Phosphor ylation of serine 256 by protein kinase B disrupts transactivation by FKHR and mediates effects of insulin on insulin-like growth factor-bind ing protein -I promoter activity through a conserved insulin response sequence. J Bioi Chern 1999; 274(24):17184-17192.
22. Kops GJ. de Ruiter NO. De Vries-Smits AM, et al. Direct control of the Forkhead transcription factor AFX by protein kinase B. Nature 1999; 398(6728) :630-634. (Pubitemid 29183692)
23. Richards JS. Sharma SC. Falender AE, et al. Expression of FKHR. FKHRLI and AFX genes in the rodent ovary: Evidence for regulation by IGF-I. estrogen and the gonadotropins. Mol Endocrinol 2002; 16(3):580-599. (Pubitemid 34214577)
24. Takaishi H, Konishi H, Matsuzaki H, et al. Regulation of nuclear translocation of forkhead transcription factor AFX by protein kinase B. Proc Natl Acad Sci USA 1999; 96(21):11836-11841. (Pubitemid 29502819)
25. Brunet A. ParkJ. Tran H, et al. Protein kinase SGK mediates survival signals by phosphor ylating the forkhead transcription factor FKHRLI (FOX03a). Mol Cell BioI 2001; 21(3):952-965. (Pubitemid 32104742)
26. Rena G. Woods YL. Prescott AR, et al. Two novel phosphor ylation sites on FKHR that are critical for its nuclear exclusion. EMBOJ 2002; 21(9):2263-2271. (Pubitemid 34516785)
27. ZhuJ. Shibasaki F, Price Ret al. Intramolecular masking of nuclear import signal on NF-AT4 by casein kinase I and MEKKI. Cell 1998; 93(5):851-861. (Pubitemid 28257590)
28. Huang H. Regan KM. Lou Z, et al. CDK2-dependent phosphor ylation of FOXOI as an apoptotic response to DNA damage. Science 2006; 314(5797):294-297. (Pubitemid 44571973)
29. Woods YL, Rena G. Morrice N, et al. The kinase DYRKIA phosphorylates the transcription factor FKHR at Ser329 in vitro, a novel in vivo phosphorylation site. Biochem J 2001; 355(Pt 3):597-607. (Pubitemid 32434075)
30. Yang JY, Zong CS, Xia W, et al. ERK promotes tumorigenesis by inhibicing FOX03a via MDM2-mediated degradation Nat Cell BioI 2008; 10(2):138-148. (Pubitemid 351194043)
31. EssersMA, Weijzen S. de Vries-Smits AM, et al. FOXO transcription factor activation by oxidative stress mediated by the small GTPase Ral and JNK. EMBO J 2004; 23(24) :4802-4812. (Pubitemid 40069710)
32. Finnberg N, El-Deiry WS. Activating FOX03a. NF-kappaB and p53 by targeting lKKs: An effective multi-faceted targeting of the tumor-cell phenotype? Cancer BiolTher 2004; 3(7):614-616. (Pubitemid 41351097)
33. Brunet A, SweeneyLB, SrurgillJF, et al. Stress-dependent regulation of FOXO transcription factors by the SIRTI deacetylase. Science 2004; 303(5666):2011-2015. (Pubitemid 38393275)
34. Accili D, Arden KC. FoxOs at the crossroads of cellular metabolism. differentiation and transformation Cell 2004; 117(4) :421-426. (Pubitemid 38610228)
35. Daitoku H, Hana M, Matsuzaki H, et al. Silent information regulator 2 potentiates Foxol-mediated transcription through its deacetylase activity. Proc Nad Acad Sci USA 2004; 101(27):10042-10047. (Pubitemid 38891191)
36. van der Horse A. Tertoolen LG, de Vries-SmitsLM, et al. FOX04 is acerylaced upon peroxide stress and deacerylared by the longevity protein hSir2(SIRT1).J BioI Chern 2004; 279(28):28873-28879. (Pubitemid 38915754)
37. Kitamura YI. Kitamura T, Kruse JP, et al. FoxOl protects against pancreatic beta cell failure through NeuroD and MafA induction Cell Metab. 2005; 2(3) :153-163
38. van der Heide LP, Smidt MP. Regulation of FoxO activity by CBP/p300-mediated acetylation. Trends in biochemical sciences 2005; 30(2):81-86. (Pubitemid 40187300)
39. Matsuzaki H. Dairoku H, Ham M, et al. Acetylation of Foxol alters its DNA-binding ability and sensitivity to phosphorylation. Proc Nad Acad Sci USA 2005; 102(32):11278-11283. (Pubitemid 41153811)
40. Wang F, Nguyen M, Qin FX, et al. SIRT2 deacecylates FOX03a in response to oxidative stress and caloric restriction Aging Cell 2007; 6(4) :505-514. (Pubitemid 47087055)
41. Plas DR, Thompson CB. Akt activation promotes degradation of tuberin and FOX03a via the proteasome.J BioI Chern 2003; 278(14):12361-12366. (Pubitemid 36800220)
42. YamagataK, Daitoku H. Takahashi Y, et al. Arginine methylation of FOXO transcription factors inhibits their phosphorylation by Akr, Mol Cell 2008; 32(2):221-231.
43. Zhao J. Brault JJ, Schild A, et al. Coordinate activation of autophagy and the proteasome pathway by FoxO transcription factor. Autophagy 2008; 4(3) :378-380. (Pubitemid 351458106)
44. Hu MC. Lee DF, Xia W, et al. IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOX03a. Cell 2004; 117(2):225-237. (Pubitemid 38496242)
45. Matsuzaki H, Daitoku H. Ham M, et al. Insulin-induced phosphorylation of FKHR (Foxol) targets to proteasomal degradation. Proc Nad Acad Sci USA 2003; 100(20):11285-11290. (Pubitemid 37205927)
46. Brenkman AB, de Keizer PL. van den Broek NJ, et al. The peptidyl-isomerase Pinl regulates p27kipl expression through inhibition of Forkhead box 0 tumor suppressors. Cancer Res 2008; 68(18) :7597-7605.
47. Brenkman AB. de Keizer PL. van den Broek NJ, et al. Mdm2 induces mono-ubiquirinaeion of FOX04. PLoS ONE. 2008; 3(7) :e2819.
48. van der Horst A. de Vries-SmitsAM. Brenkman AB, et al. FOX04 transcriptional activity is regulated by monoubiquirination and USP7/HAUSP. Nat Cell BioI 2006; 8(10):1064-1073. (Pubitemid 44473601)
49. Brunet A, Kanai F, Stehn J., et al. 14-3-3 transits to the nucleus and participates in dynamic nucleocytoplasmic transport J Cell BioI 2002; 156(5):817-828. (Pubitemid 34839865)
50. Yaffe MB. How do 14-3-3 proteins work?-Gatekeeper phosphorylation and the molecular anvil hypothesis. FEBS Lett 2002; 513(1):53-57. (Pubitemid 34242978)
51. Dong S, Kang S, Gu T.L., et al.I4-3-3 Integrates prosurvival signals mediated by the AKT and MAPK pathways in ZNFI98-FGFRI-cransformed hematopoietic cells. Blood 2007; 110(1):360-369. (Pubitemid 47026855)
52. Gomis RR, Alarcon C, Nadal C, et al. C/EBPbeta at the core of the TGFbeta cytostatic response and its evasion in metastatic breast cancer cells. Cancer Cell 2006; 10(3):203-214. (Pubitemid 44311064)
53. Gomis RR, Alarcon C, He W, et al. A FoxO-Smad synexpression group in human keratinocytes. Proc Nad Acad Sci USA 2006; 103(34):12747-12752. (Pubitemid 44298632)
54. Allen DL, Untcrman TG. Regulation of myostatin expression and myoblast differentiation by FoxO and SMAD transcription factors. AmJ Physiol Cell Physiol2007; 292(I):CI88-199.
55. Arden KC. FoxO: Linking new signaling pathways. Mol Cell 2004; 14(4):416-418. (Pubitemid 38648793)
56. Secane J, Le HY, Shen L, et al. Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation Cell 2004; 117(2):211-223. (Pubitemid 38496241)
57. Yamamura Y. Lee WL, Inoue K, et al. RUNX3 cooperates with Fox03a to induce apoptosis in gastric cancer cells.J BioI Chern 2006; 281(8) :5267-5276. (Pubitemid 43847791)
58. Nemoto S, FergussonMM. Finkel T. Nutrient availabilityregulatesSIRTI through a forkhead-dependem pathway. Science 2004; 306(5704):2105-2108. (Pubitemid 40007664)
59. Dowell P, Ono TC. Adi S, et al. Convergence of peroxisome proliferator-actlvated receptor gamma and Foxol signaling pathways.J BioI Chern 2003; 278(46) :45485-45491. (Pubitemid 37432687)
60. Douek DC. Picker LJ. Koup RA. Tvcell dynamics in HIV-l infection. Annu Rev Immunol 2003; 21 :265-304.
61. Grossman Z. Meier -Schellersheim M. Paul WE, et al. Pathogenesis of HIV infection: What the virus spares is as important as what it destroys. Nat Med 2006; 12(3) :289-295. (Pubitemid 43355074)
62. Dickson DW; Lee SC. Mattiace LA, et al. Microglia and cytokines in neurological disease. with special reference to AIDS and Alzheimer's disease. Glia 1993; 7(1):75-83
63. Mrak RE. Griffin WS. The role of chronic self-propagating glial responses in neurodegeneration: Implications for long-lived survivors of human immunodeficiency virus. J Neurov irol1997; 3(4) :241-246.
64. Zhang K. McQuibban GA. Silva C, et al. HIV-induced metalloproteinase proce ssing of the chemokine stromal cell derived factor-I causes neurodegeneration. Nat Neurosci 2003 ; 6(10) :1064-1071. (Pubitemid 37186198)
65. Koenig S. Gendelman HE. Orenstein JM, et al. Detection ofAIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 1986; 233(4768) :1089-1093. (Pubitemid 16032241)
66. Eilbott DJ, Peress N. Burger H, et al. Human immunodeficiency virus type 1 in spinal cords of acquired immunodeficiency syndrome patients with myelopathy : Expression and replication in macrophages Proc Natl Acad Sci USA 1989; 86(9) :3337-3341. (Pubitemid 19129606)
67. Navia BA. Jordan BD. Price RW: The AIDS dementia complex : I. Clinical features. Annals of Neurology 1986; 19:517-524. (Pubitemid 16085185)
68. McArthur Jc. Neurologic manifestations of AIDS. Medicine (Baltimore) 1987; 66(6):407-437. (Pubitemid 18008932)
69. Muthumani K, Choo AY. Hwang DS, et al. HIV-l Nef-induced FasL induction and bystander killing requires p38 MAPK activation. Blood 2005 ; 106(6):2059-2068. (Pubitemid 41291720)
70. Bouzar AB, Villet S. Mor in T, et al. Simian immunodeficiency viru s Vpr/Vpx proteins kill bystander noninfected CD4+ T-Iymphocytes by induction of apoptosis. Virology 2004 ; 326(1) :47-56 (Pubitemid 38943005)
71. jekle A. Keppler OT, De Clercq E, et al. In vivo evolution of human immunodeficiency viru s type 1 toward increased pathogenicity through CXCR4-mediated killing of uninfected CD4 Txells. J Virol 2003 ; 77(10):5846-5854. (Pubitemid 36538978)
72. Peng SI. Foxo in the immune system. Oncogene 2008 ; 27(16) :2337-2344.
73. Coffer PJ. Burgering BM. Forkhead-box transcription factors and thei r role in the immune system. Nat Rev Immunol 2004; 4(11) :889-899. (Pubitemid 39490764)
74. Lin L, Hron JD, Peng SI.. Regulation of NF -kappaB , Th activation and autoinflammation by the forkhead transcription factor Foxo.Ia. Immunity 2004; 21(2):203-213 (Pubitemid 39094050)
75. Asselin-Labat ML, David M, Biola-Vidamment A, et al. GILZ, a new target for the transcription factor Fox03, protects T-Iymphocytes from interleukin-2 withdrawal-induced apoptosis. Blood 2004; 104(1) :215-223. (Pubitemid 38879860)
76. Stahl M, Dijkers PE Kops GJ, et al. The forkhead transcription factor FoxO regulate s transcription of p27Kipl and Bim in response to IL-2 J Immunol 2002; 168(10):5024-5031. (Pubitemid 34495965)
77. Tang IT. Dowbenko D, Jackson A, et al. The forkhead transcription factor AFX activates apoptosis by induction of the BCL-6 transcriptional repressor. J Bioi Chem 2002 ; 277(16):14255-14265. (Pubitemid 34968040)
78. Dijkers PE Birkenkamp KU, Lam EW, et al. FKHR-Ll can act as a critical effector of cell death induced by cytokine withdrawal: Protein kinase B-enhanced cell survival through maintenance of mitochondrial integrity. J Cell Bioi 2002; 156(3):531-542. (Pubitemid 34839900)
79. Erlacher M, Labi V, Manzi C, et al. Puma cooperates with Bim, the rate-limiting BH3-only protein in cell death during lymphocyte development, in apoptosis induction. J Exp Med 2006; 203(13):2939-2951. (Pubitemid 46026171)
80. Selliah N. Finkel TH. Biochemical mechanisms of HIV induced T-cell apoptosis , Cell Death Differ 2001; 8(2) :127-136 (Pubitemid 32201360)
81. Li G, Elder RT, Qin K, et al. Phosphatase type 2A-dependent and -independent pathways for ATR phosphorylation of Chk1. J Bioi Chem 2007 ; 282(10):7287-7298. (Pubitemid 47093684)
82. Andersen JL. DeHart JL. Zimmerman ES, et al. HIV-l Vpr-induced apoptosis is cell cycle dependent and requires Bax but not ANT. PLoS Parhog 2006; 2(12):el27.
83. Lai M, Chen J. The role of Vpr in HIV-l disease progression is independent of its G2 arrest induction function. Cell Cycle 2006; 5(19) :2275-2280. (Pubitemid 44546565)
84. Andersen JL. Zimmerman ES. DeHart JL, et al. ATR and GADD45alpha mediate HIV-l Vpr-induced apoptosis. Cell Death Differ 2005; 12(4) :326-334. (Pubitemid 40520684)
85. Roshal M. Kim B, Zhu Y, et al. Activation of the ATR-mediated DNA damage response by the HIV-l viral protein R. J Bioi Chem 2003; 278(28):25879-25886. (Pubitemid 36835349)
86. Fletcher TM 3rd. Brichacek B. Sharova N, et al. Nuclear import and cell cycle arrest functions of the HIV-l Vpr protein are encoded by two separate genes in HIV-2ISIV(SM). EMBO J 1996; 15(22):6155-6165. (Pubitemid 26397887)
87. Zimmerman ES. Sherman MP, Blackett JL, et al. Human immunodeficiency virus type 1 Vpr induces DNA replication stress in vitro and in vivo. J Viro12006; 80(21):10407-10418. (Pubitemid 44628888)
88. Belzile JP, Duisit G, Rougeau N, et al. HIV-l Vpr-mediated G2 arre st involves the DDBI-CUL4AVPRBP E3 ubiquitin ligase. PLoS Pathog 2007; 3(7):e85
89. Kino T, Chrousos GP. Human immunodeficiency virus type-I accessory protein Vpr: A causative agent of the AIDS-related insulin resistance/ lipodystrophy syndrome? Ann N Y Acad Sci 2004; 1024:153-167. (Pubitemid 38879600)
90. Kino T, De Martino MU. Charmandari E, et al. HIV-l accessoryprotein Vpr inhibits the effect of insulin on the Foxo subfamily of forkhead transcription factors by interfering with their binding to 14-3-3 proteins: Potential clinical implications regarding the insulin resistance of HIV-l-infected patients Diabetes 2005; 54(1):23-31. (Pubitemid 40105091)
91. Martinez-Gac L. Marques M, Garcia Z, et al. Control of cyclin G2 mRNA expression by forkhead transcription factors: Novel mechanism for cell cyclecontrol by phosphoinositide 3-kinase and forkhead. Mol Cell BioI 2004; 24(5) :2181-2189. (Pubitemid 38248955)
92. Tran H, Brunet A, Grenier JM, et al. DNA repair pathway stimulated by the forkhead transcription factor FOX03a through the Gadd45 protein. Science 2002; 296(5567) :530-534. (Pubitemid 34408672)
93. Delpuech 0, Griffiths B. East P, et al. Induction ofMxil-SR alpha by FOX03a contributes to repression of Myc-dependent gene expression. Mol Cell BioI 2007; 27(13) :4917-4930. (Pubitemid 47016141)
94. Dabrowska A, Kim N. Aldovini A. Tat-induced FOX03a is a key mediator of apoptosis in Hlv-l-infected human CD4+ Tvlymphocytes. J Immunol2008; 181(12):8460-8477.
95. Frankel AD, Pabo CO. Cellular uptake of the tat protein from human immunodeficiency virus. Cell 1988,55(6):1189-1193. (Pubitemid 19020071)
96. Li CJ, Wang C, Friedman DJ, et al. Reciprocal modulations between p53 and Tat of human immunodeficiency virus type 1. Proc Nad Acad Sci USA 1995; 92(12) :5461-5464.
97. Riou C, Yassine-DiabB, VangrevenyngheJ, et al. Convergence ofTCR and cytokine signaling leads to FOX03a phosphorylation and drives the survival of CD4+ central memory T-celIs.J Exp Med 2007; 204(1):79-91. (Pubitemid 46148759)
98. van Grevenynghe J. Procopio FA, He Z, et al. Transcription factor FOX03a controls the persistence of memory CD4(+) T-cells during HIV infection. Nat Med 2008, 14(3):266-274. (Pubitemid 351347916)
99. Carter CA, Ehrlich LS. Cell biology of HIV-l infection of macrophages. Annu Rev Microbiol 2008, 62:425-443.
100. Vazquez N, Greenwell-Wild T, Marinos NJ, et al. Human immunodeficiency virus type l -induced macrophage gene expression includes the p21 gene. A target for viral regulation. J Virol 2005 ; 79(7) :4479-4491. (Pubitemid 40388385)
101. Bren GD. Whitman J, Cummins N, et al. Infected cell killing by HIV-l protease promotes NF-kappaB dependent HIV-l replication. PLoS ONE 2008, 3(5):e2112.
102. Francois F, Klotrnan ME. Phosphatidylinositol 3-kinase regulates human immunodeficiencyvirus type 1 replication following viral entry in primary CD4+ T-Iymphocytes and macrophages. J Virol 2003; 77(4):2539-2549. (Pubitemid 36222778)
103. Chugh P. Bradel-Tretheway B. Monteiro-Filho CM, et al. Akt inhibitors as an HIV-l infected macrophage- specific anti-viral therapy. Retrovirology 2008; 5:11.
104. Deregibus MC, Cantaluppi V, Doublier S, et al. HIV-I-Tat protein activates phosphatidylinositol 3-kinase/ AKT-dependent survival pathways in Kapos i's sarcoma cells. J BioI Chern 2002 ; 277(28) :25195-25202. (Pubitemid 34951826)
105. WolfD, Witte V, Laffert B, et al. HIV-l Nef associatedPAK and PI3-kinases stimulate Akt-independent Bad-phosphorylation to induce anti-apoptotic signals. Nat Med 2001, 7(11) :1217-1224. (Pubitemid 33063777)
106. Borgatti P, Zauli G. Colamussi ML, et al. Extracellular HIV-l Tat protein activates phosphaci dylinositol 3- and Akt/PKB kinases in CD4+ T-Iymphoblastoid Jurkat cells. Eur J Immunol 1997, 27(11) :2805-2811. (Pubitemid 27478347)
107. Huang Y, Erdmann N. Peng H, et al. TRAIL-mediated apoptosis in HIV-l-infected macrophages is dependent on the inhibition of Akr-I phosphorylation. J Immunol2006, 177(4):2304-2313. (Pubitemid 44200990)
108. Cui M, Huang Y, Zhao Y, et al. Transcription factor FOX03a mediates apoptosis in HIV-l-infected macrophages. J Immunol 2008; 180(2):898-906.
109. Boisse L, Gill MJ. Power C. HIV infection of the central nervous system: Clinical features and neuropathogenesis. Neurol Clin 2008, 26(3):799-819, x Review. (Pubitemid 352037443)
110. Gonzalez-Duarte A, Roblnson-Papp J, Simpson DM. Diagnosis and management of Hl'V-associated neuropathy. Neurol Clin 2008; 26(3) :821-832, x Review.
111. Masliah E, Ge N, Mucke I. Pathogenesis of HIV-l associated neurodegeneration. Crit Rev Neurobiol 1996, 10(1):57-67.
112. Wolkow CA, Kimura KD, Lee MS, et al. Regulation of C. elegans life-span by insulinlike signaling in the nervous system. Science 2000; 290(5489) :147-150.
113. Miyamoto K. Araki KY, Naka K, et al. Foxoda is essential for maintenance of the hematopoietic stem cell pool. Cell Stem Cell 2007, 1(1):101-112. (Pubitemid 46865800)
114. Tothova Z, Kollipara R, Huntly BJ, et al. FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell 2007, 128(2) :325-339. (Pubitemid 46137992)
115. Wang L, Zhang ZG, Gregg SR, et al. The Sonic hedgehog pathway mediates carbamylated erythropoietin-enhanced proliferation and differentiation of adult neural progenitor cells. J Bioi Chern 2007; 282(44):32462-32470. (Pubitemid 350106478)
116. Bakker WJ. van Dijk TB. Parren-van Amelsvoort M, et al. Differential regulation of Foxoda target genes in erythropoiesis Mol Cell Bioi 2007; 27(10):3839-3854. (Pubitemid 46726190)
117. Sathyanarayana P. Dev A. Fang Jet al. EPO receptor circuits for primary erythroblast survival. Blood 2008; 111(11) :5390-5399.
118. Behl C. Davis JB. Lesley R, et al. Hydrogen peroxide mediates amyloid beta protein toxicity. Cell 1994; 77(6) :817-827. (Pubitemid 24187680)
119. Wu Y, Wu Z. Butko P, et al. Amyloid-beta-induced pathological behaviors are suppressed by Ginkgo biloba extract EGb 761 and ginkgolides in transgenic Caenorhabditis elegans. J Neurosci 2006 ; 26(50) :13102-13113. (Pubitemid 44954628)
120. Jiang H. Wu YC. Nakamura M, et al. Parkinson's disease genetic mutations increase cell susceptibility to stress: Mutant alpha-synuclein enhances H202- and Sin-l-induced cell death. Neurobiol Aging 2007; 28(11) :1709-1717 (Pubitemid 47384952)
121. Davila D. Torres-Aleman I. Neuronal death by oxidative stress involves activation of FOX03 through a two-arm pathway that activates stress kinases and attenuates insulin-like growth factor 1 signaling. Mol Bioi Cell 2008; 19(5):2014-2025.
122. Shinoda S. Schindler CK. Meller Ret al. Bim regulation may determine hippocampal vulnerability after injurious seizures and in temporal lobe epilepsy.J Clin Invest 2004; 113(7) :1059-1068 (Pubitemid 38544128)
123. GilleyJ. Coffer PJ. Ham J. FOXO transcription factors directly activate bim gene expressionand promote apoptosis in sympathetic neurons. J Cell Bioi 2003; 162(4) :613-622. (Pubitemid 37022939)
124. Sanderson TH, Kumar R. Murariu-Dobrin AC, et al. Insulin activates the PI3K-Akt survival pathway in vulnerable neurons following global brain ischemia. Neurol Res 2009; Epub ahead of print
125. Obexer P, Geiger K. Ambros PF, et al. FKHRLl-mediated expression of Noxa and Bim induces apoptosis via the mitochondria in neuroblastoma cells. Cell Death Differ 2007; 14(3):534-547.
126. Zhu Z. Zhang Q. Yu Z, et al. Inhibiting cell cycle progression reduces reactive astrogliosis initiated by scratch injury in vitro and by cerebral ischemia in vivo. Glia 2007; 55(5):546-558. (Pubitemid 46383184)
127. Di Giovanni S, MovsesyanV, Ahmed F, et al. Cell cycle inhibition provides neuroprorection and reduces glial proliferation and scar formation after traumatic brain injury. Proc Natl Acad Sci USA 2005; 102(23):8333-8338. (Pubitemid 40800089)
128. Franke H. Sauer C. Rudolph C, et al. P2 receptor-mediated stimulation of the PI3-K/ Akt-pathway in vivo. Glia 2008; Epub ahead of print.